![](/img/cover-not-exists.png)
A Phase II Study of Telisotuzumab Vedotin in Patients With câMET-positive Stage IV or Recurrent Squamous Cell Lung Cancer (LUNG-MAP Sub-study S1400K, NCT03574753)
Waqar, Saiama N., Redman, Mary W., Arnold, Susanne M., Hirsch, Fred R., Mack, Philip C., Schwartz, Lawrence H., Gandara, David R., Stinchcombe, Thomas E., Leighl, Natasha B., Ramalingam, Suresh S., TaJournal:
Clinical Lung Cancer
DOI:
10.1016/j.cllc.2020.09.013
Date:
October, 2020
File:
PDF, 135 KB
2020